Table of Contents
What is difference between Lantus and Toujeo?
The biggest difference is that Toujeo is highly concentrated, making injection volume much smaller than Lantus. In terms of side effects, one important factor to consider is that Toujeo may offer less risk for hypoglycemia, or low blood glucose, than Lantus, because it helps keep blood sugar levels more consistent.
What type of insulin is Toujeo?
Toujeo contains insulin glargine, which is a type of long-acting insulin. It comes as a liquid solution that you’ll inject under your skin.
What is the best time of day to take Toujeo?
Toujeo may be given at any time of the day; however, once you have chosen a time, it is best to inject Toujeo within three hours of that time every day. Toujeo is a long-acting insulin that lasts up to 36 hours. Although Toujeo is usually administered once a day, some people may benefit from twice-daily administration.
How good is Toujeo?
User Reviews for Toujeo SoloStar. Toujeo SoloStar has an average rating of 3.9 out of 10 from a total of 44 ratings on Drugs.com. 20% of reviewers reported a positive experience, while 60% reported a negative experience.
What are the side effects of Toujeo insulin?
What are the mild side effects of Toujeo?
- skin rash.
- itchy skin.
- skin thickening or changes in an area where you injected the drug.
- infections, such as the common cold.
- swelling, especially of the arms or legs.
- cough.
- low blood sugar*
- injection site reactions*
What is the side effects of Toujeo?
What are the common side effects of Toujeo?
What are the side effects of Toujeo?
Who should not take Toujeo?
You should not use Toujeo if you are allergic to insulin, or if you are having an episode of hypoglycemia (low blood sugar) or diabetic ketoacidosis (call your doctor for treatment). Toujeo is not approved for use by anyone younger than 6 years old, and some brands are for use only in adults.
Does insulin harm your kidneys?
In healthy subjects, insulin has little or no effect on renal hemodynamics, glomerular filtration rate, or permeability to albumin. In patients with noninsulin-dependent diabetes, hyperinsulinemia selectively increases urinary albumin excretion.